Equity · Healthcare

SGMO

Sangamo Therapeutics, Inc. · OTC Markets OTCPK

$0.18 +36.05% 1D Finazon · prior-day close

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for SGMO to draw a line in its place.

The chart above plots the price of SGMO over the range selected — one day to the full history — drawn by TradingView from their own data.

Market cap $74.1M

Avg volume 275.2K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 17, 2026

SGMO insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 25 May 2026

Open-market buys 0

Open-market sells 0

Non-trade filings 5

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value

25 May 2026 Davis Gregory D Head of Research & Technology Tax withheld 1,630 $0K

25 May 2026 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Tax withheld 4,036 $1K

25 May 2026 Jain Nikunj Principal Accounting Officer Tax withheld 1,919 $0K

25 May 2026 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Tax withheld 12,613 $2K

25 May 2026 Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY Tax withheld 4,036 $1K

SGMO earnings

SEC EDGAR

Date Period EPS Revenue

31 Mar 2026 Q1 2026 $-0.08 —

31 Dec 2025 FY 2025 $-0.44 —

30 Sep 2025 Q3 2025 $-0.11 —

30 Jun 2025 Q2 2025 $-0.08 —

31 Mar 2025 Q1 2025 $-0.14 —

31 Dec 2024 FY 2024 $-0.49 —

30 Sep 2024 Q3 2024 $0.04 —

30 Jun 2024 Q2 2024 $-0.18 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

SGMO insider trades

SGMO earnings

SGMO institutional holders